Hemoglobin genetics: Recent contributions of GWAS and gene editing

Human Molecular Genetics

Volumn 25, Issue R2, 2016, Pages R99-R105

  Smith, Elenoe C ^a,b   Orkin, Stuart H ^a,b,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HEMOGLOBIN F; HEMOGLOBIN GAMMA CHAIN; LEUKEMIA LYMPHOMA RELATED FACTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; BCL11A PROTEIN, HUMAN; CARRIER PROTEIN; NUCLEAR PROTEIN;

BCL11A GENE; ENHANCER REGION; GENE; GENE CLUSTER; GENE DISRUPTION; GENE EXPRESSION; GENE LOCUS; GENE MAPPING; GENE SILENCING; GENE SWITCHING; GENETIC TRANSCRIPTION; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GLOBIN GENE; HEMOGLOBINOPATHY; HUMAN; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; REGULATORY SEQUENCE; REPRESSOR GENE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; GENE EDITING; GENETICS; METABOLISM;

CARRIER PROTEINS; FETAL HEMOGLOBIN; GAMMA-GLOBINS; GENE EDITING; GENOME-WIDE ASSOCIATION STUDY; HUMANS; NUCLEAR PROTEINS;

EID: 84994065773     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddw170     Document Type: Review

References (51)

1. Thein, S.L. (2013) The molecular basis of beta-thalassemia. Cold Spring Harb. Perspect. Med., 3, a011700.
2. Platt, O.S., Brambilla, D.J., Rosse, W.F., Milner, P.F., Castro, O., Steinberg, M.H. and Klug, P.P. (1994) Mortality in sickle cell disease. Life expectancy and risk factors for early death. N. Engl. J. Med., 330, 1639-1644.
3. Wilber, A., Nienhuis, A.W. and Persons, D.A. (2011) Transcriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities. Blood, 117, 3945-3953.
4. Tuan, D. and London, I.M. (1984) Mapping of DNase I-hypersensitive sites in the upstream DNA of human embryonic epsilon-globin gene in K562 leukemia cells. Proc. Natl. Acad. Sci. U. S. A., 81, 2718-2722.
5. Grosveld, F., van Assendelft, G.B., Greaves, D.R. and Kollias, G. (1987) Position-independent, high-level expression of the human beta-globin gene in transgenic mice. Cell, 51, 975-985.
6. Parker, S.C., Stitzel, M.L., Taylor, D.L., Orozco, J.M., Erdos, M.R., Akiyama, J.A., van Bueren, K.L., Chines, P.S., Narisu, N., Program, N.C.S., et al. (2013) Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants. Proc. Natl. Acad. Sci. U. S. A., 110, 17921-17926.
7. Deng, W., Rupon, J.W., Krivega, I., Breda, L., Motta, I., Jahn, K.S., Reik, A., Gregory, P.D., Rivella, S., Dean, A., et al. (2014) Reactivation of developmentally silenced globin genes by forced chromatin looping. Cell, 158, 849-860.
8. Drissen, R., Palstra, R.J., Gillemans, N., Splinter, E., Grosveld, F., Philipsen, S. and de Laat, W. (2004) The active spatial organization of the beta-globin locus requires the transcription factor EKLF. Genes Dev., 18, 2485-2490.
9. Song, S.H., Hou, C. and Dean, A. (2007) A positive role for NLI/Ldb1 in long-range beta-globin locus control region function. Mol. Cell, 28, 810-822.
10. Menzel, S., Garner, C., Gut, I., Matsuda, F., Yamaguchi, M., Heath, S., Foglio, M., Zelenika, D., Boland, A., Rooks, H., et al. (2007) A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15. Nat. Genet., 39, 1197-1199.
11. Uda, M., Galanello, R., Sanna, S., Lettre, G., Sankaran, V.G., Chen, W., Usala, G., Busonero, F., Maschio, A., Albai, G., et al. (2008) Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia. Proc. Natl. Acad. Sci. U. S. A, 105, 1620-1625.
12. Lettre, G., Sankaran, V.G., Bezerra, M.A., Araujo, A.S., Uda, M., Sanna, S., Cao, A., Schlessinger, D., Costa, F.F., Hirschhorn, J.N., et al. (2008) DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc. Natl. Acad. Sci. U. S. A., 105, 11869-11874.
13. Thein, S.L., Menzel, S., Peng, X., Best, S., Jiang, J., Close, J., Silver, N., Gerovasilli, A., Ping, C., Yamaguchi, M., et al. (2007) Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults. Proc. Natl. Acad. Sci. U. S. A, 104, 11346-11351.
14. Sankaran, V.G., Joshi, M., Agrawal, A., Schmitz-Abe, K., Towne, M.C., Marinakis, N., Markianos, K., Berry, G.T. and Agrawal, P.B. (2013) Rare complete loss of function provides insight into a pleiotropic genome-wide association study locus. Blood, 122, 3845-3847.
15. Sankaran, V.G., Menne, T.F., Scepanovic, D., Vergilio, J.A., Ji, P., Kim, J., Thiru, P., Orkin, S.H., Lander, E.S. and Lodish, H.F. (2011) MicroRNA-15a and-16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13. Proc. Natl. Acad. Sci. U. S. A., 108, 1519-1524.
16. Sankaran, V.G., Menne, T.F., Xu, J., Akie, T.E., Lettre, G., Van Handel, B., Mikkola, H.K., Hirschhorn, J.N., Cantor, A.B. and Orkin, S.H. (2008) Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science, 322, 1839-1842.
17. Sankaran, V.G., Xu, J., Ragoczy, T., Ippolito, G.C., Walkley, C.R., Maika, S.D., Fujiwara, Y., Ito, M., Groudine, M., Bender, M.A., et al. (2009) Developmental and species-divergent globin switching are driven by BCL11A. Nature, 460, 1093-1097.
18. Xu, J., Peng, C., Sankaran, V.G., Shao, Z., Esrick, E.B., Chong, B.G., Ippolito, G.C., Fujiwara, Y., Ebert, B.L., Tucker, P.W., et al. (2011) Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing. Science, 334, 993-996.
19. Basak, A., Hancarova, M., Ulirsch, J.C., Balci, T.B., Trkova, M., Pelisek, M., Vlckova, M., Muzikova, K., Cermak, J., Trka, J., et al. (2015) BCL11A deletions result in fetal hemoglobin persistence and neurodevelopmental alterations. J. Clin. Invest., 125, 2363-2368.
20. Funnell, A.P., Prontera, P., Ottaviani, V., Piccione, M., Giambona, A., Maggio, A., Ciaffoni, F., Stehling-Sun, S., Marra, M., Masiello, F., et al. (2015) 2p15-p16.1 microdeletions encompassing and proximal to BCL11A are associated with elevated HbF in addition to neurologic impairment. Blood, 126, 89-93.
21. Tsang, J.C., Yu, Y., Burke, S., Buettner, F., Wang, C., Kolodziejczyk, A.A., Teichmann, S.A., Lu, L. and Liu, P. (2015) Single-cell transcriptomic reconstruction reveals cell cycle and multi-lineage differentiation defects in Bcl11a-deficient hematopoietic stem cells. Genome Biol., 16, 178.
22. Bauer, D.E., Kamran, S.C., Lessard, S., Xu, J., Fujiwara, Y., Lin, C., Shao, Z., Canver, M.C., Smith, E.C., Pinello, L., et al. (2013) An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level. Science, 342, 253-257.
23. Canver, M.C., Smith, E.C., Sher, F., Pinello, L., Sanjana, N.E., Shalem, O., Chen, D.D., Schupp, P.G., Vinjamur, D.S., Garcia, S.P., et al. (2015) BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis. Nature, 527, 192-197.
24. Canver, M.C., Bauer, D.E., Dass, A., Yien, Y.Y., Chung, J., Masuda, T., Maeda, T., Paw, B.H. and Orkin, S.H. (2014) Characterization of genomic deletion efficiency mediated by clustered regularly interspaced palindromic repeats (CRISPR)/Cas9 nuclease system in mammalian cells. J. Biol. Chem., 289, 21312-21324.
25. Kurita, R., Suda, N., Sudo, K., Miharada, K., Hiroyama, T., Miyoshi, H., Tani, K. and Nakamura, Y. (2013) Establishment of immortalized human erythroid progenitor cell lines able to produce enucleated red blood cells. PLoS One, 8, e59890.
26. Masuda, T., Wang, X., Maeda, M., Canver, M.C., Sher, F., Funnell, A.P., Fisher, C., Suciu, M., Martyn, G.E., Norton, L.J., et al. (2016) Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin. Science, 351, 285-289.
27. Feng, Q. and Zhang, Y. (2001) The MeCP1 complex represses transcription through preferential binding, remodeling, and deacetylating methylated nucleosomes. Genes Dev, 15, 827-832.
28. Hendrich, B. and Bird, A. (1998) Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell. Biol., 18, 6538-6547.
29. Amaya, M., Desai, M., Gnanapragasam, M.N., Wang, S.Z., Zu Zhu, S., Williams, D.C Jr. and Ginder, G.D. (2013) Mi2beta-mediated silencing of the fetal gamma-globin gene in adult erythroid cells. Blood, 121, 3493-3501.
30. Gnanapragasam, M.N., Scarsdale, J.N., Amaya, M.L., Webb, H.D., Desai, M.A., Walavalkar, N.M., Wang, S.Z., Zu Zhu, S., Ginder, G.D. and Williams, D.C. Jr. (2011) p66Alpha-MBD2 coiled-coil interaction and recruitment of Mi-2 are critical for globin gene silencing by the MBD2-NuRD complex. Proc. Natl. Acad. Sci. U. S. A., 108, 7487-7492.
31. Xu, J., Bauer, D.E., Kerenyi, M.A., Vo, T.D., Hou, S., Hsu, Y.J., Yao, H., Trowbridge, J.J., Mandel, G. and Orkin, S.H. (2013) Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A. Proc. Natl. Acad. Sci. U. S. A., 110, 6518-6523.
32. Costa, F.C., Fedosyuk, H., Chazelle, A.M., Neades, R.Y. and Peterson, K.R. (2012) Mi2beta is required for gamma-globin gene silencing: temporal assembly of a GATA-1-FOG-1-Mi2 repressor complex in beta-YAC transgenic mice. PLoS Genet., 8, e1003155.
33. Tanabe, O., McPhee, D., Kobayashi, S., Shen, Y., Brandt, W., Jiang, X., Campbell, A.D., Chen, Y.T., Chang, C., Yamamoto, M., et al. (2007) Embryonic and fetal beta-globin gene repression by the orphan nuclear receptors, TR2 and TR4. EMBO J., 26, 2295-2306.
34. Shinkai, Y. and Tachibana, M. (2011) H3K9 methyltransferase G9a and the related molecule GLP. Genes Dev., 25, 781-788.
35. Tachibana, M., Matsumura, Y., Fukuda, M., Kimura, H. and Shinkai, Y. (2008) G9a/GLP complexes independently mediate H3K9 and DNA methylation to silence transcription. EMBO J., 27, 2681-2690.
36. Tachibana, M., Sugimoto, K., Fukushima, T. and Shinkai, Y. (2001) Set domain-containing protein, G9a, is a novel lysinepreferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3. J. Biol. Chem., 276, 25309-25317.
37. Tachibana, M., Ueda, J., Fukuda, M., Takeda, N., Ohta, T., Iwanari, H., Sakihama, T., Kodama, T., Hamakubo, T. and Shinkai, Y. (2005) Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9. Genes Dev., 19, 815-826.
38. Barski, A., Cuddapah, S., Cui, K., Roh, T.Y., Schones, D.E., Wang, Z., Wei, G., Chepelev, I. and Zhao, K. (2007) High-resolution profiling of histone methylations in the human genome. Cell, 129, 823-837.
39. Guelen, L., Pagie, L., Brasset, E., Meuleman, W., Faza, M.B., Talhout, W., Eussen, B.H., de Klein, A., Wessels, L., de Laat, W., et al. (2008) Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions. Nature, 453, 948-951.
40. Rice, J.C., Briggs, S.D., Ueberheide, B., Barber, C.M., Shabanowitz, J., Hunt, D.F., Shinkai, Y. and Allis, C.D. (2003) Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains. Mol. Cell, 12, 1591-1598.
41. Chen, X., Skutt-Kakaria, K., Davison, J., Ou, Y.L., Choi, E., Malik, P., Loeb, K., Wood, B., Georges, G., Torok-Storb, B., et al. (2012) G9a/GLP-dependent histone H3K9me2 patterning during human hematopoietic stem cell lineage commitment. Genes Dev., 26, 2499-2511.
42. Vedadi, M., Barsyte-Lovejoy, D., Liu, F., Rival-Gervier, S., Allali-Hassani, A., Labrie, V., Wigle, T.J., Dimaggio, P.A., Wasney, G.A., Siarheyeva, A., et al. (2011) A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells. Nat. Chem. Biol., 7, 566-574.
43. Krivega, I., Byrnes, C., de Vasconcellos, J.F., Lee, Y.T., Kaushal, M., Dean, A. and Miller, J.L. (2015) Inhibition of G9a methyltransferase stimulates fetal hemoglobin production by facilitating LCR/gamma-globin looping. Blood, 126, 665-672.
44. Renneville, A., Van Galen, P., Canver, M.C., McConkey, M., Krill-Burger, J.M., Dorfman, D.M., Holson, E.B., Bernstein, B.E., Orkin, S.H., Bauer, D.E., et al. (2015) EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression. Blood, 126, 1930-1939.
45. Bradner, J.E., Mak, R., Tanguturi, S.K., Mazitschek, R., Haggarty, S.J., Ross, K., Chang, C.Y., Bosco, J., West, N., Morse, E., et al. (2010) Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease. Proc. Natl. Acad. Sci. U. S. A, 107, 12617-12622.
46. Esrick, E.B., McConkey, M., Lin, K., Frisbee, A. and Ebert, B.L. (2015) Inactivation of HDAC1 or HDAC2 induces gamma globin expression without altering cell cycle or proliferation. Am. J. Hematol., 90, 624-628.
47. Cao, H. and Stamatoyannopoulos, G. (2006) Histone deacetylase inhibitor FK228 is a potent inducer of human fetal hemoglobin. Am. J. Hematol., 81, 981-983.
48. Cao, H., Stamatoyannopoulos, G. and Jung, M. (2004) Induction of human gamma globin gene expression by histone deacetylase inhibitors. Blood, 103, 701-709.
49. Kronke, J., Udeshi, N.D., Narla, A., Grauman, P., Hurst, S.N., McConkey, M., Svinkina, T., Heckl, D., Comer, E., Li, X., et al. (2014) Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells. Science, 343, 301-305.
50. Lu, G., Middleton, R.E., Sun, H., Naniong, M., Ott, C.J., Mitsiades, C.S., Wong, K.K., Bradner, J.E. and Kaelin, W.G. Jr. (2014) The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins. Science, 343, 305-309.
51. Dulmovits, B.M., Appiah-Kubi, A.O., Papoin, J., Hale, J., He, M., Al-Abed, Y., Didier, S., Gould, M., Husain-Krautter, S., Singh, S.A., et al. (2016) Pomalidomide reverses gammaglobin silencing through the transcriptional reprogramming of adult hematopoietic progenitors. Blood, 127, 1481-1492.